Institutional review board statement
The trial was approved by the regional ethics committee of Berlin, Germany (Landesamt für Gesundheit und Soziales, Approval Number 13/0491-EK 11) and was registered in the EU clinical trials register (2013-000823-15) and the American National Institute of Health register (NCT02096068).